Why Is Targeted PTM Analysis Essential in Proteomics Research?
- Phosphorylation
- Acetylation
- Ubiquitination
- Glycosylation
- Methylation
- Lipidation
- The onset time of modification
- The peak of activation
- The rate of de-modification
- Synergistic or antagonistic relationships among modification sites
- Disease subtype stratification
- Prediction of drug response
- Identification of new therapeutic targets
- IMAC/TiO₂ (phosphopeptide enrichment)
- Antibody-based enrichment (acetylation, ubiquitination, methylation)
- K-ε-GG (diGly) antibody enrichment (ubiquitinated substrates)
- Capture low-abundance, dynamic, and biologically meaningful modification sites
- Elucidate the operating principles of cellular signaling networks
- Support studies of drug mechanism of action and target validation
- Advance precision-medicine research
- Address blind spots of conventional protein-abundance analyses
In modern life-science research, proteomics has evolved from cataloguing proteins toward elucidating how proteins are regulated and how they shape cellular states. A central theme in this transition is the systematic characterization of post-translational modifications (PTMs). Across basic biology, studies of disease mechanisms, and drug-target discovery, targeted PTM analysis (targeted PTM proteomics) has become an indispensable approach. This article explains why targeted PTM analysis is a major focus in proteomics from four perspectives: biological mechanisms, technical challenges, application scenarios, and experimental design logic.
PTMs Constitute Core Determinants of Protein Functional States
1. PTMs Directly Determine Protein Activity States
A protein’s primary structure (amino-acid sequence) cannot fully specify its physiological function.
Only after proteins undergo diverse PTMs within the cell, such as:
They enter functionally regulatable states that respond to signaling pathways.
PTMs determine:
(1) Whether a protein can bind its substrates or interaction partners.
(2) When a protein is activated versus targeted for degradation.
(3) Whether it participates in signaling cascades.
(4) Whether it is directed to specific organelles.
Therefore, studies that consider only protein abundance while ignoring modification states often yield incomplete and sometimes even misleading conclusions about protein function.
PTMs Are Frequently of Extremely Low Abundance and Require Targeted Strategies for Accurate Measurement
1. Low Site Occupancy Is the Norm Rather Than the Exception
For most PTMs, site stoichiometry (occupancy) is typically below 1%.
For example:
(1) Certain phosphorylation sites within a single protein may increase only 2–5-fold even after stimulation.
(2) Ubiquitination can be triggered transiently and is readily removed by the cell.
(3) Acetylation or methylation may occur on fewer than 5% of protein molecules.
Consequently, conventional shotgun proteomics using data-dependent acquisition (DDA) often fails to capture the PTMs of interest.
2. Targeted PTM Analysis Renders Low-Abundance Modifications Measurable
Targeted mass-spectrometry methods (e.g., PRM/SRM) enable quantitative monitoring of extremely low-abundance modified peptides by narrowing the monitoring to diagnostic ions, allocating maximal acquisition time, and improving the signal-to-noise ratio for specific modified peptides. As a result, sensitivity is substantially higher than in untargeted workflows.
Targeted PTM Analysis Uncovers Real-Time Dynamics of Cellular Signaling Networks
1. “Unchanged Abundance but Dramatic PTM Shifts” Reflects the Essence of Signal Transduction
Activation of many pathways is not driven by changes in protein abundance, but by rapid and highly reversible PTMs.
For example:
(1) MAPK/ERK signaling: dual phosphorylation of key kinases determines signaling intensity.
(2) Immune signaling: ubiquitin-chain linkage types directly influence protein fate (K48 vs K63).
(3) Metabolic regulation: acetylation/deacetylation modulates metabolic-enzyme activity and mitochondrial state.
Thus, total protein abundance alone often cannot explain cellular phenotypes, whereas targeted PTM analysis can provide the kinetic information that more directly drives signaling-network behavior.
2. Quantifying PTMs Can Reveal Temporal Regulatory Mechanisms
PRM/SRM combined with time-course sampling can delineate:
Such dynamic measurements are particularly important for investigating drug mechanisms of action, immune activation, and stress-response processes.
PTMs Are Directly Linked to Diagnosis, Prognosis, and Target Discovery
1. PTMs Are Key Molecular Biomarkers in Cancer and Immune Diseases
Targeted PTM analysis enables accurate quantification of disease-associated modifications, facilitating:
2. Pharmacodynamic Evaluation Requires Monitoring Target Modification States Rather Than Protein Abundance
For many small-molecule inhibitors or antibody therapeutics, the primary effect is the modulation of a specific modification site on the target. Targeted PTM quantification can directly evaluate on-target pharmacological effects and is therefore an important component of modern drug development.
Common Technical Strategies for Targeted PTM Analysis
1. PTM Enrichment to Improve Capture Efficiency
Common enrichment approaches include:
2. Targeted Mass Spectrometry: PRM as a Mainstream Approach
Parallel reaction monitoring (PRM) on high-resolution instruments (e.g., Orbitrap platforms) can simultaneously provide high selectivity, low background noise, and a wide linear dynamic range, and is well suited to complex samples (tissues, serum, FFPE). When needed, selected reaction monitoring (SRM) on triple-quadrupole platforms can further enhance sensitivity.
3. Standard Peptides and Internal-Standard Systems
High-quality quantification relies on standard peptides, typically stable isotope-labeled (SIL) peptides. These standards enable correction of inter-sample variation, improve quantitative accuracy, and support absolute quantification.
Application Scenarios for Targeted PTM Analysis
Signaling-pathway interrogation (e.g., ERK, AKT, NF-κB), studies of drug mechanism of action (MoA), screening of kinase inhibitors and immunomodulators, evaluation of protein degraders (PROTACs), development of tumor biomarkers, cell-cycle research, investigations of epigenetic mechanisms, and studies of stress and metabolic regulation share a common feature: their key conclusions depend on precise quantification of specific modification sites rather than global changes in protein abundance.
Targeted PTM Analysis Has Become One of the Most Valuable Directions in Modern Proteomics
Targeted PTM analysis is important because it can:
With continued advances in mass spectrometry, enrichment strategies, and data-analysis tools, targeted PTM analysis will play an increasingly central role in life-science research. MtoZ Biolabs integrates state-of-the-art mass-spectrometry platforms, optimized enrichment workflows, and targeted-quantification expertise to provide end-to-end targeted PTM analysis services, from enrichment to PRM/SRM measurement and downstream data mining, thereby supporting higher-quality and more publication-ready research outcomes.
MtoZ Biolabs, an integrated chromatography and mass spectrometry (MS) services provider.
Related Services
Targeted Post-Translational Modification (PTM) Detection Service
How to order?
